Literature DB >> 9608902

The genetic basis for variation in antibody response to vaccines.

G A Poland1, R M Jacobson.   

Abstract

Following a brief review of important concepts of vaccine response and vaccine immunology, recent reports on genetic determinants of vaccine response are reviewed. Recent data demonstrating significant associations with particular human leukocyte antigen genes and responsiveness to measles and hepatitis B vaccines are discussed, along with the influence of Km and Gm allotype genes on pneumococcal polysaccharide vaccines. These recent findings have important considerations for research, vaccine development, and clinical practice.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9608902     DOI： 10.1097/00008480-199804000-00017

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN： 1040-8703            Impact factor:   2.856


  15 in total

1.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

2.  Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine.

Authors:  Holly D Clifford; Stephanie T Yerkovich; Siew-Kim Khoo; Guicheng Zhang; John Upham; Peter N Le Souëf; Peter Richmond; Catherine M Hayden
Journal:  Immunogenetics       Date:  2011-09-23       Impact factor: 2.846

3.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

4.  Genetic appraisal of serological response post vaccination against enterotoxaemia (ET) in Malpura and Avikalin sheep.

Authors:  G R Gowane; Najif Akram; L L L Prince; Ved Prakash; Arun Kumar
Journal:  Trop Anim Health Prod       Date:  2017-03-23       Impact factor: 1.559

5.  Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

6.  Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; Victor J Johnson; Nevin W Wilson; Raymond E Biagini; Wei Wang; Bonnie Frye; David N Weissman; Dori R Germolec; Michael I Luster; Michael M Barmada
Journal:  Vaccine       Date:  2013-09-26       Impact factor: 3.641

Review 7.  Vaccine immunogenetics: bedside to bench to population.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

Review 8.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

Review 9.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

10.  Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease.

Authors:  Ray Borrow; Elaine Stanford; Pauline Waight; Matthew Helbert; Paul Balmer; Rosalind Warrington; Mary Slack; Robert George; Elizabeth Miller
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.